4//SEC Filing
Paravasthu Mukund 4
Accession 0001562180-24-007567
CIK 0001645113other
Filed
Nov 5, 7:00 PM ET
Accepted
Nov 6, 4:27 PM ET
Size
14.3 KB
Accession
0001562180-24-007567
Insider Transaction Report
Form 4
NovoCure LtdNVCR
Paravasthu Mukund
Chief Operating Officer
Transactions
- Award
Ordinary Shares
2024-11-04+30,138→ 33,597 total - Award
Stock Option (Right to Buy)
2024-11-04$16.59/sh+45,620$756,836→ 45,620 totalExercise: $16.59Exp: 2034-11-03→ Ordinary Shares (45,620 underlying) - Sale
Ordinary Shares
2024-11-02$16.69/sh−44$734→ 3,459 total
Footnotes (3)
- [F1]Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
- [F2]Represents restricted share units that are scheduled to vest in equal parts on November 4, 2025, 2026 and 2027, subject to the reporting person's continued employment through such dates.
- [F3]Options to buy 45,620 ordinary shares will vest in equal installments on each of November 4, 2025, 2026, 2027 and 2028, subject to the reporting person's continued employment through such dates.
Issuer
NovoCure Ltd
CIK 0001645113
Entity typeother
Related Parties
1- filerCIK 0002039078
Filing Metadata
- Form type
- 4
- Filed
- Nov 5, 7:00 PM ET
- Accepted
- Nov 6, 4:27 PM ET
- Size
- 14.3 KB